Abstract. We measured the free concentration of 1,25-dihydroxyvitamin D (1,25[OHJ2D) using centrifugal ultrafiltration, and the level of vitamin D-binding protein (DBP) in 24 normal subjects, 17 pregnant subjects, and 25 alcoholic subjects with liver disease. Our objective was to determine whether the increase in total 1,25(OH)2D levels in pregnant women and the reduction in total 1,25(OH)2D levels in subjects with liver disease reflected a true difference in free 1,25(OH)2D levels or whether such differences were due solely to the variations in DBP levels (and thus, the amount of 1,25[OH]2D bound) in these groups. In subjects with liver disease the mean total 1,25(OH)2tD concentration (22.6±12.5 pg/ml) and the mean DBP concentration (188±105 fsg/ dl) were nearly half the normal values (41.5±11.5 pg/ ml and 404±124 ,g/dl, respectively, P < 0.001), whereas the mean free 1,25(OH)2D level was similar to normal values (209±91 fg/ml and 174±46 fg/ml, respectively). In contrast, in pregnant subjects the mean total 1,25(OH)2D level (82±21 pg/ml) and mean DBP level (576±128 Ag/dl) were significantly higher than normal (P < 0.001). Although the mean percent free 1,25-(OH)2D level in pregnant subjects was below normal (0.359±0.07% vs. 0.424±0.07%, P < 0.001), the mean free 1,25(OH)2D level was 69% higher than normal (294±98 fg/ml vs. 174±46 fg/ml, P < 0.001). When data from all three groups were combined, there was a linear correlation between total 1,25(OH)2D and DBP levels but not between DBP and percent free 1,25(OH)2D levels; the increased DBP levels in the pregnant subjects were associated with less of an effect on percent free 1,25(OH)2D than were the reduced DBP levels in the subjects with liver disease.
Introduction
Vitamin D and its metabolites circulate in blood almost entirely bound to serum proteins (1) . The best studied of these proteins is vitamin D-binding protein (DEP),' an alpha globulin with a molecular weight of -58,000 (2) , although lipoproteins and albumin are also known to bind the vitamin D metabolites (3) . The high affinity of DBP for the vitamin D metabolites, coupled with the large excess of DBP in blood compared with the vitamin D metabolites, has made it difficult to measure the free or unbound fraction of the circulating metabolites. Instead, levels of the free metabolites have been estimated from measurements of DBP and total metabolite concentrations, using previous determinations of the affinity constant of purified DBP or dilute serum for the vitamin D metabolite of interest (4) . However, estimates of the affinity constant of human DBP for 25-hydroxyvitamin D (250HD) vary from the affinity appears to be at least one order of magnitude less than that for 250HD (2, 4) . The exact relationship between these affinity constant determinations, which generally are made using dilute serum at 4VC, and the actual free levels of 1,25(OH)2D in undiluted blood at 370C is unknown.
Determination of free 1,25(OH)2D levels in human blood is important because it is still unclear whether the free or the total concentration of this hormone is the physiologically important concentration. Total 1, 25 (OH)2D levels are increased during pregnancy (4, 8-1 1), as are DBP levels (4, 8, (12) (13) (14) . Pregnant women do not develop hypercalcemia, as might be expected in persons with elevated 1,25(OH)2D levels, although increased intestinal calcium absorption has been observed (15) . Perhaps the increase in total 1,25(OH)2D reflects an increase in the amount of 1,25(OH)2D bound to DBP (analogous to the rise in thyroid hormone and cortisol during pregnancy)
and not an increase in the free concentration. Patients with liver disease (16-18) and the nephrotic syndrome (19, 20) have DBP levels that are lower than normal. Low 1,25(OH)2D concentrations have been reported in these conditions by some investigators (21, 22) but not by others (23, 24) . If levels are indeed lower, this circumstance may be caused by a reduction in the amount of 1,25(OH)2D bound to DBP, although abnormalities in hepatic or renal metabolism of vitamin D in such patients may be partially responsible. The finding of osteomalacia in some patients with liver disease (22, 25) or the nephrotic syndrome (26) is difficult to reconcile with the concept that the 1,25(OH)2D bound to DBP is physiologically inactive, unless the free 1,25(OH)2D levels are also reduced in these conditions. Thus, in all these patients, knowledge of free 1,25(OH)2D levels would be helpful in understanding the pathophysiology involved.
In an attempt to find a technique that could measure free 1,25(OH)2D levels directly, accurately, and rapidly, we compared measurements of free 1,25(OH)2D levels made by centrifugal ultrafiltration and by equilibrium dialysis. We then used centrifugal ultrafiltration to measure free 1,25(OH)2D levels in subjects with low (chronic liver disease), normal, and high (pregnancy) DBP levels to determine the relationship between free 1,25(OH)2D and DBP levels.
Methods
Subjects. Blood was obtained from 24 normal volunteers (eight men and 16 women, aged 24-50 yr), 17 pregnant subjects, 15 of whom were in their third trimester of pregnancy, and 25 alcoholic subjects (7 women and 18 men, aged 22 to 70) with clinical or histologic evidence of liver disease. The normal volunteers and the subjects with liver disease were taking no drugs known to influence levels of vitamin D metabolites or DBP, except for three normal subjects who were taking oral contraceptives. The pregnant subjects were ingesting each day a prenatal vitamin supplement containing 400 IU vitamin D2. No subject had a disorder in calcium metabolism that was clinically apparent. The serum was stored at -201C until assayed.
Analyses. The centrifugal ultrafiltration technique of Hammond et al. (27) Table I . Subjects with liver disease had the lowest total 1,25(OH)2D (22.6±12.5 pg/ml) and DBP (188±105 ,gg/dl) levels, and the highest percent free 1,25(OH)2D
(1.098±0.5%). Pregnant subjects had the highest total 1,25(OH)2D (82±21 pg/ml) and DBP (576±128 sg/dl) levels and the lowest percent free 1,25(OH)2D (0.359±0.07%). The mean free 1,25(0H1)D levels did not differ significantly for subjects with liver disease and normal subjects (174±46 vs. 209±91 fg/ml, respectively, P > 0.05). In contrast, in pregnant subjects the mean free 1,25(OH)2D level was significantly higher than that in normal subjects (294±98 fg/ml vs. 174±46 fg/ml, respectively). Normal men and women did not differ in their mean free 1,25(OH)2D levels (women, 177±53 fg/ml; men, 168±33 fg/ml). In the three normal women who were ingesting oral contraceptives, the mean free 1,25(OH)2D level (235±47 fg/ml) was between the values for normal (174±46 fg/ml) and pregnant subjects (294±98 fg/ml), even though these three women had a mean DBP level (603±228 gg/dl) comparable to that of the pregnant subjects (576±128 Ag/dl).
There was a linear correlation between total serum 1,25(OH)2D levels and DBP levels when data from all three groups of subjects were combined (Fig. 1 , r = 0.757, P < 0.001). There was no correlation when data from the normal or pregnant subjects were analyzed separately.
The correlation between DBP and percent free 1,25(OH)2D was not linear when data from all three groups were combined (Fig. 2) , but the percent free 1,25(OH)2D could be expressed as a power function of DBP (Fig. 3) , with a significant correlation coefficient (r = -0.815, P < 0.001). When data from the subjects with liver disease and pregnant subjects were analyzed separately, significant linear correlations could be found between percent free 1,25(OH)2D and DBP levels (r = -0.447, P < 0.05 and r = -0.615, P < 0.01, for subjects with liver disease and pregnant subjects, respectively), but the slopes of the regression lines were quite different. Normal subjects showed no significant correlation between these measurements. No correlation between free 1,25(OH)2D and DBP levels was observed when data from all three groups were combined (Fig. 4) . (4, (8) (9) (10) (11) (12) (13) (14) . Liver disease can lower DBP levels (16-18) and, according to some reports (22) , including our own data, can lower total 1,25(OH)2D levels. To determine whether free 1,25(OH)2D levels were also affected by these conditions, we measured total and free 1,25(OH)2D and DBP levels in such patients.
Alcoholic subjects with liver disease had substantially lower DBP and total 1,25(OH)2D levels than did normal subjects but did not have lower free 1,25(OH)2D levels. Although we did not determine whether these particular alcoholic subjects had evidence of vitamin D deficiency (e.g., osteomalacia), one of us (Bikle, D. D., H. K. Genant, C. Cann, R. R. Recker, B. P. Halloran, and G. J. Strewler, manuscript submitted for publication) has found no evidence of osteomalacia on transcortical biopsy of the iliac crest in another group of alcoholics. Conceivably, the available 1,25(OH)2D levels are adequate for normal target tissue response in these subjects with liver disease despite the reduced total 1,25(OH)2D levels. In contrast, the free 1,25(OH)2D levels in the pregnant subjects were elevated, although not to the degree to which total 1,25(OH)2D levels were increased. From a physiologic perspective, an elevated free 1,25(OH)2D level would help to provide the additional calcium required for the developing fetus and is consistent with the increased intestinal calcium absorption observed during pregnancy (15 
